The incidence and mortality of small-cell lung cancer worldwide make this disease a notable
health-care issue. Diagnosis relies on histology, with the use of immunohistochemical …

… Small-cell lung cancer (SCLC) represents about 15% of all lung cancers and is marked
by an exceptionally high proliferative rate, strong predilection for early metastasis and poor …

… Small-cell lung carcinoma is an aggressive form of lung cancer that is strongly associated
with cigarette smoking and has a tendency for early dissemination. Increasing evidence has …

Neuroendocrine tumors account for approximately 20% of lung cancers; most (≈15%) are
small cell lung cancer (SCLC). These NCCN Clinical Practice Guidelines in Oncology for …

… It is the cancer most commonly associated with various paraneoplastic syndromes, including
the syndrome of inappropriate antidiuretic hormone secretion, paraneoplastic cerebellar …

Small cell lung cancer (SCLC) is an aggressive cancer of neuroendocrine origin, which is
strongly associated with cigarette smoking. Patients typically present with a short duration of …

… Small cell lung cancer (SCLC) is an aggressive disease that accounts for approximately 14%
of all lung cancers. In … Unlike nonsmall cell lung cancer (NSCLC), in which major advances …

… Among patients with lung cancers, the proportion of those with small cell lung cancer (SCLC)
has decreased over the last decade. SCLC is staged as limited-stage disease and …

… settings for patients with extensive-stage or relapsed small-cell lung cancer (SCLC),
respectively. In the first-line setting, the addition of the anti-programmed cell death 1 ligand 1 (PD-L1…

… Chemotherapy versus chemotherapy plus irradiation in limited small cell lung cancer.
Results of a controlled trial with 5 years follow-up. Br J Cancer 1986; 54: 7–17. 6. Warde, P. …